ADA Antikörper
-
- Target Alle ADA Antikörper anzeigen
- ADA (Adenosine Deaminase (ADA))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ADA Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (IF)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human ADA (NP_000013.2).
- Isotyp
- IgG
- Top Product
- Discover our top product ADA Primärantikörper
-
-
- Applikationshinweise
- IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- ADA (Adenosine Deaminase (ADA))
- Andere Bezeichnung
- ADA (ADA Produkte)
- Hintergrund
- This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.
- Molekulargewicht
-
Observed_MW: 43kDa
Calculated_MW: 40kDa
- Gen-ID
- 100
- UniProt
- P00813
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Ribonucleoside Biosynthetic Process
-